Publication

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical Trials Network

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Peter K. Smith, Duke UniversityRobert E. Michler, Montefiore-Einstein Heart CenterY. Joseph Woo, University of PennsylvaniaJohn H. Alexander, Duke UniversityJohn D. Puskas, Emory UniversityDavid A. D'Alessandro, Montefiore-Einstein Heart CenterRebecca T. Hahn, Columbia UniversityJudson B. Williams, Duke UniversityJohn M. Dent, University of VirginiaT. Bruce Ferguson, Jr., East Carolina UniversityEllen Moquete, Mt Sinai School of MedicinePierre Page, Hôpital du Sacré-Cœur de MontréalNeal O. Jeffries, National Heart, Lung, and Blood InstitutePatrick T. O'Gara, Brigham & Women's HospitalDeborah D. Ascheim, Mt Sinai School of Medicine
Language
  • English
Date
  • 2012-01-01
Publisher
  • Elsevier
Publication Version
Copyright Statement
  • © 2012 by The American Association for Thoracic Surgery.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0022-5223
Volume
  • 143
Issue
  • 1
Start Page
  • 111
End Page
  • U175
Grant/Funding Information
  • National Heart Lung and Blood Institute; Canadian Institute of Health Research; National Institute of Neurological Diseases and Stroke
Abstract
  • Objective: Patients with coronary artery disease complicated by moderate ischemic mitral regurgitation have demonstrably poorer outcome than do patients with coronary artery disease but without mitral regurgitation. The optimal treatment of this condition has become increasingly controversial, and a randomized trial evaluating current practices is warranted. Methods: We describe the design and initial execution of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial. Results: This is an ongoing prospective, multicenter, randomized, controlled clinical trial designed to test the safety and efficacy of mitral repair in addition to coronary artery bypass grafting in the treatment of moderate ischemic mitral regurgitation. Conclusions: The results of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial will provide long-awaited information on controversial therapies for this morbid disease process.
Author Notes
  • Deborah D. Ascheim, M.D., InCHOIR, Department of Health Evidence and Policy, Mount Sinai School of Medicine, New York, Phone: 212-659-9567, Fax: 212-423-2998, deborah.ascheim@mssm.edu.
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items